Valeant hopes to name Perrigo’s Joseph Papa as next CEO

Valeant Pharmaceuticals International Inc. is finalizing a contract to name Perrigo Co. Chief Executive Joseph Papa as its next CEO, hoping a fresh face and an experienced pharmaceutical-industry boss will calm nervous investors.